Hodges Capital Management Inc. Gsk PLC Transaction History

Hodges Capital Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 07, 2021	SELL	$34.27 - $40.01 $188,827 - $220,455	-5,510 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$37.87 - $43.58 $4,165 - $4,793	110 Added 2.04%	5,510 $225,000
Q1 2020 May 04, 2020	SELL	$32.47 - $48.83 $32,470 - $48,830	-1,000 Reduced 15.63%	5,400 $205,000
Q2 2019 Aug 22, 2019	SELL	$39.4 - $42.7 $252,160 - $273,280	-6,400 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$37.8 - $42.69 $128,519 - $145,146	-3,400 Reduced 34.69%	6,400 $245,000
Q1 2018 May 03, 2018	BUY	$36.18 - $40.15 $354,564 - $393,470	9,800 New	9,800 $383,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hodges Capital Management Inc. with notifications on news.